ReviewMicroorganisms2026
Therapeutic Management of Probiotics and Prebiotic Products to Modulate Gut Microbiome by Healthcare Services.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prescription and recommendation of prebiotics and probiotics by healthcare professionals remain an evolving area of research. Despite increasing recognition of their benefits in modulating the gut microbiome, healthcare professionals including dietitians, often lack standardised guidelines and sufficient training to integrate them into practice. Barriers to implementation include insufficient clinical evidence, cost, uncertainty regarding strain-specific efficacy, and a lack of consensus on appropriate therapeutic applications. Studies indicate that while many healthcare professionals acknowledge the potential benefits of these products, their hesitancy arises from insufficient supporting research evidence and associated education. Future efforts should concentrate on enhancing clinical guidelines, improving educational programs for healthcare professionals, and conducting large-scale trails to establish evidence-based recommendations. Additionally, integrating gut microbiome sequencing into clinical decision-making could improve personalised nutrition and optimise the prescription of prebiotics and probiotics. Further research is necessary to address knowledge gaps and promote effective, evidence-based use of these interventions by healthcare professionals. This review explores current prescribing practices, knowledge, and perceptions of healthcare professionals regarding prebiotics and probiotics with a particular focus on the evidence, education, and implementation gaps that may influence their clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.